Form 4: Hims & Hers Health COO Melissa Baird Reports Stock Transactions

Melissa Baird, Chief Operating Officer of Hims & Hers Health, Inc., reports the acquisition and disposal of Class A Common Stock and Restricted Stock Units on June 14, 2024, due to vesting of RSUs and tax withholding.

Summary

• On June 14, 2024, Melissa Baird, the Chief Operating Officer of Hims & Hers Health, Inc., engaged in transactions involving the company's Class A Common Stock and Restricted Stock Units (RSUs).
• Baird acquired 73,146 shares of Class A Common Stock through the vesting of RSUs.
• Simultaneously, Baird disposed of 28,778 shares of Class A Common Stock to cover tax withholding obligations related to the RSU vesting at a price of $23.75 per share.
• Following these transactions, Baird directly owns 585,800 shares of Class A Common Stock.
• The transactions also involved the vesting of various tranches of RSUs, including 16,297, 18,713, 811, 49, 8,295, 1,626, 1,222, and 26,133 RSUs, which convert into Class A Common Stock.
• After these transactions, Baird holds varying amounts of RSUs subject to service-based vesting requirements.

Sentiment

Score: 6

Explanation: The document is neutral, reporting standard stock transactions related to executive compensation. There are no indications of positive or negative sentiment.

Positives

• The vesting of RSUs indicates that Baird is meeting the service-based requirements, suggesting continued involvement with the company.

Negatives

• The disposal of shares to cover tax obligations, while standard, reduces Baird's overall holdings of Class A Common Stock.

Risks

• There are no specific risks mentioned in this document, as it primarily details stock transactions related to RSU vesting and tax obligations.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates standard compensation practices involving RSUs and tax withholding.

Comparison to Industry Standards

• Stock-based compensation, including RSUs, is a common practice among publicly traded companies, particularly in the technology and healthcare sectors, to align employee incentives with shareholder value.
• Companies like Teladoc Health and GoodRx also utilize RSU grants as part of their compensation packages for executives.
• The vesting schedules and tax withholding practices described in the filing are consistent with standard industry practices.

Stakeholder Impact

• The transactions have a minor impact on shareholders, as they reflect standard executive compensation practices.
• Employees who hold RSUs are impacted positively as their RSUs vest over time.

Key Dates